Atlas Capital Advisors LLC Celldex Therapeutics, Inc. Transaction History

Atlas Capital Advisors LLC

  • $656 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
BUY
$22.7 - $37.57 $61,290 - $101,439
2,700 New
2,700 $75.9 Million
Q2 2022

Aug 16, 2022
SELL
$20.5 - $37.33 $55,350 - $100,791
-2,700 Closed
0 $0
Q2 2021

Jul 30, 2021
SELL
$20.71 - $35.37 $6,213 - $10,611
-300 Reduced 10.0%
2,700 $90,000
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $44,970 - $68,250
3,000 New
3,000 $52,000

Others Institutions Holding CLDX

# of Institutions
196
Shares Held
66M
Call Options Held
1.68M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.05B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email